Analyst ratings and price target adjustments are significant drivers of stock price movements. Raymond James' decision to maintain a Strong Buy rating and nearly double the price target for Dyne Therapeutics is a strong positive signal to the market, suggesting higher confidence in the company's future performance. This is likely to attract investor attention and could lead to increased buying pressure, driving up the stock price in the short term.